VYNE Therapeutics: Q2 Earnings Insights


VYNE Therapeutics VYNE reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM.

Here’s what investors need to know about the announcement.


VYNE Therapeutics beat estimated earnings by 23.53%, reporting an EPS of $-0.13 versus an estimate of $-0.17.

Revenue was down $4.13 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.26 which was followed by a 7.25% increase in the share price the next day.

Here’s a look at VYNE Therapeutics’s past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.16 -0.24 -0.32 -0.35
EPS Actual 0.10 -0.20 -0.36 -0.35
Revenue Estimate 370K 4.12M 4.76M 6.21M
Revenue Actual 178K 2.29M 4.09M 4.26M

To track all earnings releases for VYNE Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Image and article originally from www.benzinga.com. Read the original article here.